European Companies Search Engine
Company statute Hrb15 Jun 2015 German Trade Register Announcements, Germany
Overview
Text
HRB 504390: STRATEC Biomedical AG, Birkenfeld, Gewerbestr. 37, 75217 Birkenfeld. The Annual General Meeting of May 22, 2015 approved the amendment of the Articles of Association in Sections 3 (notices), 4 (share capital, new authorized capital 2015/I, new contingent capital VII (2015), 8 (composition, term of office), 14 (place and convening) and 15 (expiration of the Annual General Meeting). The authorisation of the Executive Board by resolution of the Annual General Meeting of April 14, 2011 to increase the share capital of the company by up to EUR 5,500,000.00 (Authorized Capital 2011/I) has been revoked. The Annual General Meeting of May 22, 2015 repealed the conditional capital (Conditional Capital IV (2011)) decided on April 14, 2011. By resolution of the Annual General Meeting of May 22, 2015, the Board of Management is authorized, with the approval of the Supervisory Board, to increase the company's share capital once or several times by up to a total of EUR 5,500,000.00 against cash and/or in-case deposits by the approval of the Supervisory Board. Shareholders' subscription rights may be excluded. (Authorised capital 2015/I). The Annual General Meeting of May 22, 2015 approved the conditional increase in the share capital by up to a total of EUR 800,000.00. (Conditional Capital VII (2015)).
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STRATEC SE, Birkenfeld, Germany.
The visualizations for "STRATEC Biomedical AG - Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
